Clarivate Plc

Clarivate Plc disclosed under Item 5.02 on July 29, 2026 that Jonathan Collins, its Executive Vice President and Chief Financial Officer, resigned effective August 7, 2026, and that Michael Easton was appointed CFO effective August 8, 2026. Collins' departure is explicitly characterized as not resulting from any disagreement with the company, its management, board, or independent auditors. Easton's appointment is an internal promotion; his background and compensation arrangements are detailed in the 8-K exhibit. The CFO transition at Clarivate, a global information analytics company, comes during a period when investors have been closely watching the company's margin improvement trajectory and debt reduction efforts.

Clarivate Plc filed an 8-K on July 29, 2026 under Items 2.02 and 7.01 to report its financial results for the second quarter ended June 30, 2026, accompanied by an investor supplemental. The press release and supplemental materials are furnished as exhibits and are not deemed 'filed' for Section 18 purposes. Clarivate provides data and analytics products to academic, scientific, and IP-intensive industries including its Web of Science, Derwent, CompuMark, and CPA Global platforms. Detailed revenue, adjusted EBITDA, free cash flow, and 2026 guidance are in the attached press release and supplemental exhibit.

Clarivate Plc entered into a Stock and Asset Purchase Agreement on July 3, 2026 to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for $600 million total consideration: $500 million in cash at closing (subject to customary working capital, cash, and debt adjustments) plus $100 million in deferred consideration. The deal does not require shareholder approval and is expected to close by end of calendar year 2026, subject to regulatory approvals. This is a material divestiture that will meaningfully reduce Clarivate's revenue and operating footprint while generating $500 million in near-term cash proceeds.

Clarivate Plc furnished a Regulation FD press release and investor presentation on July 6, 2026 announcing the agreement to sell its Life Sciences and Healthcare business to an Altaris LLC affiliate for $600 million ($500M cash + $100M deferred). This is the Reg FD companion filing to the same-day material agreement 8-K (Item 1.01) — the investor presentation (Exhibit 99.2) contains detailed financial rationale and transaction terms. The divestiture streamlines Clarivate's portfolio and generates significant cash proceeds, expected to close by year-end 2026.

Simon Webster joined Clarivate PLC as President, Intellectual Property (succeeding Maroun Mourad) effective June 10, 2026, and directly owns 4,229,500 Ordinary Shares. Significant pre-existing share ownership for an incoming business unit president; Webster's substantial equity stake aligns his interests with shareholders as he assumes leadership of Clarivate's IP segment.

Maroun S. Mourad, President of Clarivate PLC's Intellectual Property segment, will depart effective June 9, 2026, and will remain as a non-executive advisor through September 30, 2026; his separation agreement provides a $450,000 pro-rated 2026 target bonus, COBRA reimbursement, and a UK tax equalization payment in exchange for a release of claims; Simon Webster succeeds him. Orderly leadership transition with a 3-month advisory period for knowledge transfer; the compensation package is modest relative to comparable separations.

Clarivate plc held its 2026 Annual General Meeting on May 14, 2026, with 559,077,435 of 642,179,542 eligible shares represented (87.1%). All five director nominees were elected: Andrew Snyder (488,258,437 for, 40,178,878 against — notable ~7.6% opposition), Jane Okun Bomba (526,186,715 for), Kenneth Cornick (527,732,735 for), Usama N. Cortas (524,312,366 for), and Suzanne Heywood (502,086,682 for). The filing also includes an Item 8.01 (Other Events) disclosure covering additional matters disclosed in connection with the annual meeting. Snyder's higher-than-typical opposition vote is noteworthy for a large-cap company.